Multicenter, Randomized, Double-Blind Placebo-Controlled

Project: Research project

Description

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets, in Androgenetic Alopecia in Males with a Comparator Arm
StatusActive
Effective start/end date3/1/163/30/21

Funding

  • Allergan, Inc.

Fingerprint

Alopecia
Tablets
Placebos
2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido(4,3-b)indol-5(2H)-yl)acetic acid